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a b s t r a c t
RNA interference (RNAi) mediated by short hairpin-RNA (shRNA) expressing plasmids can induce speciﬁc
and long-term knockdown of speciﬁc mRNAs in eukaryotic cells. To develop a vector-based RNAi model
for Schistosoma mansoni, the schistosome U6 gene promoter was employed to drive expression of shRNA
targeting reporter ﬁreﬂy luciferase. An upstream region of a U6 gene predicted to contain the promoter
was ampliﬁed from genomic DNA of S. mansoni. A shRNA construct driven by the predicted U6 promoter
targeting luciferase was assembled and cloned into plasmid pXL-Bac II, the construct termed pXL-BacII_SmU6-shLuc. Luciferase expression in transgenic ﬁbrosarcoma HT-1080 cells was signiﬁcantly reduced
96 h following transduction with plasmid pXL-BacII_SmU6-shLuc, which encodes luciferase mRNA-speciﬁc shRNA. In a similar fashion, schistosomules of S. mansoni were transformed with the SmU6-shLuc
or control constructs. Fireﬂy luciferase mRNA was introduced into transformed schistosomules after
which luciferase activity was analyzed. Signiﬁcantly less activity was present in schistosomules transfected with pXL-BacII_SmU6-shLuc compared with controls. The ﬁndings revealed that the putative S. mansoni U6 gene promoter of 270 bp in length was active in human cells and schistosomes. Given that the U6
gene promoter drove expression of shRNA from an episome, the ﬁndings also indicate the potential of this
putative RNA polymerase III dependent promoter as a component regulatory element in vector-based
RNAi for functional genomics of schistosomes.
Ó 2011 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

1. Introduction
Draft genomes of Schistosoma japonicum and Schistosoma mansoni were reported recently (Berriman et al., 2009; Schistosoma
japonicum Genome Sequencing and Functional Analysis Consortium, 2009). New information in genome sequences will provide
leads for development of new interventions for control and treatment of schistosomiasis (Brindley et al., 2009), which relies solely
of the anthelmintic drug praziquantel at this time. Tools are in
development to determine the importance of the new genomic
sequences of schistosomes (Beckmann et al., 2007; Brindley and
Pearce 2007; Kines et al., 2008; Mann et al., 2008), although there
are difﬁculties with investigating the complex genomes of helminth
parasites such as the schistosomes in contrast to model, free-living
species. RNA interference (RNAi) is active in schistosomes, has been
q
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used to investigate increasing numbers of gene targets in most
developmental stages, and is being optimized for high-throughput
screens (Stefanic et al., 2010 and references therein).
Despite its utility, RNAi frequently leads to only transient gene
silencing and, in addition, may be inaccessible to some developmental stages and/or tissues of schistosomes. In vivo, e.g. vectorbased, RNAi approaches that lead to integration of transgenes
encoding cassettes that express small interfering RNAs (siRNAs)
can circumvent deﬁciencies with exogenous RNAi approaches by
providing continuous and/or conditional gene silencing (ter Brake
et al., 2006; Sliva and Schnierle, 2010). Recently, it has been
demonstrated that pseudotyped murine leukemia virus (MLV)
can be employed to transduce developmental stages of schistosomes, leading to chromosomal integration of retroviral transgenes
and transgene reporter activity (Kines et al., 2008, 2010; Yang
et al., 2010). Moreover, a vector-based RNAi approach has been
reported in which the MLV transgene encoded a long hairpin
RNA speciﬁc for a schistosome protease involved in hemoglobinolysis (Tchoubrieva et al., 2010).
In insect, mammalian, avian and some pathogenic protozoa, RNA
polymerase III (Pol III) promoter-based DNA vectors can express

0020-7519/$36.00 Ó 2011 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.ijpara.2011.02.004

Author's personal copy

784

M.A. Ayuk et al. / International Journal for Parasitology 41 (2011) 783–789

siRNA or short hairpin RNA (shRNA) (Brummelkamp et al., 2002;
Gou et al., 2003; Wakiyama et al., 2005; Linford et al., 2009). However, this has not been demonstrated in schistosomes. Here we describe a promoter-like element from the U6 gene of S. mansoni, a Pol
III, non-coding RNA gene that is a component of eukaryotic spliceosome machinery (see Copeland et al., 2009). An episomal plasmid
that included a U6 gene promoter driving a short hairpin transcript
designed to target mRNA encoding ﬁreﬂy luciferase was constructed. After transfection of human ﬁbrosarcoma cells and schistosomules with the construct, signiﬁcantly less reporter luciferase
activity was seen in the transformed human cells and schistosomes.
These ﬁndings demonstrated the activity of a 270 bp promoter-like
sequence of the schistosome U6 non-coding RNA gene to drive transcription of short transcripts from episomes delivered to both human cells and schistosomules of S. mansoni. The ﬁndings indicate
the likely utility of this U6 gene promoter containing construct
for vector-based RNAi approaches in schistosomes.
2. Materials and methods
2.1. Schistosomules
Biomphalaria glabrata snails infected with the NMRI (Puerto
Rican) strain of S. mansoni were supplied by Dr. Fred Lewis, Biomedical Research Institute, Rockville, MD, USA. Cercariae released
from infected B. glabrata snails were mechanically transformed
into schistosomules. Brieﬂy, cercariae were concentrated by centrifugation (425g/10 min) and washed once with schistosomule wash
medium, RPMI 1640 supplemented with 1x penicillin, streptomycin, fungizone (1  PSF) and 10 mM HEPES (Mann et al., 2010).
Cercarial tails were sheared off by 20 passes through 22 gauge
emulsifying needles after which schistosomule bodies were isolated from tails by Percoll gradient centrifugation (Lazdins et al.,
1982). Schistosomula were washed three times in wash medium
and cultured for up to 2 weeks at 37 °C under 5% CO2 in air in modiﬁed Basch’s medium (Basch, 1981) supplemented with washed
human erythrocytes, at a density of 1 ll packed red cells per ml
of culture medium (Mann et al., 2010).
2.2. Isolation of a U6 gene promoter-like sequence
The sequence and predicted structure of the U6 small nRNA of
S. mansoni, GenBank accession number L25920, have been
described (Gu and Reddy, 1994; Copeland et al., 2009). The 109
nucleotides (nt) of the U6 RNA were employed as the query to
search the Sanger Institute’s S. mansoni shotgun reads (Sanger)
database,
(http://www.sanger.ac.uk/cgi-bin/blast/submitblast/
s_mansoni). An identical match was located to sequences in contig
shisto3397e03.p1k. Flanking sequences upstream of the copy of the
U6 gene in this contig were targeted for PCR, using primers SmU6F,
50 -TATCAGTGGTCTAGATGTATGCTTG-30 , and SmU6R, 50 -GCTAATC
TTCTCTGTATCGTTCCA-30 . The genome of S. mansoni includes
between nine and 55 copies of the U6 gene (Copeland et al., 2009).
Sequences (474 bp) upstream and ﬂanking the U6 gene as well as
part of the 50 -terminus of the U6 gene were ampliﬁed from
genomic DNA of S. mansoni (prepared as in Morales et al., 2007),
cloned into the TOPO TA plasmid (Invitrogen) and the sequence identity conﬁrmed to be identical to that in contig shisto3397e03.p1k.
2.3. Construction of shRNA expression vectors targeting ﬁreﬂy
luciferase
The two-step PCR approach of Gou et al. (2003) and Linford
et al. (2009) was utilized to construct plasmid vectors for in vivo
episomal RNAi. The approach involves two rounds of PCR using

one universal primer, speciﬁc for the promoter and two unique target sequences; the ﬁrst oligonucleotide to add the sense strand of
the shRNA, the second to add the loop region and anti-sense
strand. For the hairpin sense strand sequence, we utilized 21 residues, nt 851–871, (50 -GTGCGCTGCTGGTGCCAACCC-30 -), of the ﬁreﬂy luciferase gene in pGL3 because this site and target sequence
length have been demonstrated in earlier reports of episomal vector RNAi to lead to complete or near complete knockdown of luciferase activity in Drosophila Schneider 2 cells, NIH-3T3 mouse
ﬁbroblasts and L2 rat lung epithelia cells (Gou et al., 2003;
Wakiyama et al., 2005). Two rounds of PCR were employed to generate the ﬁnal shRNA constructs, using forward primer U6SF1 , 50 GCGCGCGGATCCGAGTGTATGTGCATTTGGTTG-30 , and two reverse
primers, Luc851R1, 50 -TCTCTTGAAGGGTTGGCACCAGCAGCGCAC
GGATTT CGCAC ATCACTAAC-30 and Luc851R2, 50 -GCGCGCCTCGA
GAAAAAGTGCGCTGCTGG TGCCAA CCCTCTCTTGAA-30 . The ﬁnal
PCR product comprised the S. mansoni U6 promoter, the sense
strand of the shRNA hairpin, a loop TTCAAGAGA (9 bp) (Brummelkamp et al., 2002) region, the antisense strand of the hairpin, and
the U6 termination sequence, TTTTT (Gou et al., 2003). In addition,
BamHI (GGATCC) and XhoI (CTCGAG) sites were introduced
upstream of the promoter and after the TTTTT terminator, respectively, to facilitate cloning. As a control vector, we constructed a
cassette where the 21 target residues (nt 851–871) of the luciferase gene were ‘scrambled’ as follows, 50 -ACCTACTGGGCAGGGA
GCCGC-30 , using the same forward primer (above) and the following reverse primers, ScramLuc851 R1, 50 -TCTCTTGAAA CCTAC
TGGGCAGGGAGCCGCGGATTTCGCACATCACTAAC-30 ; ScramLuc851
R2, 50 -GCGCGCCTCGAGAAAAAGCGGCTCCCTGCCCAGTAG GTTCTCT
TGAA-30 . Thermal cycling conditions and reaction volumes of
Linford et al. (2009) were employed.
The ﬁnal products were sized by agarose gel electrophoresis,
eluted from the gel, cleaved with BamHI and XhoI, and ligated into
linearized plasmid pXL-BacII at the multiple cloning site within the
transposon’s inverted terminal repeats (Li et al., 2005). Top10 Escherichia coli cells (Invitrogen) were transformed with the ligation
products and transformed colonies cultured on Luria–Bertani broth
(LB) agar-ampicillin (100 lg/ml). Maxipreps of plasmid DNA were
prepared from single bacterial colonies using PerfectPrep Endofree
Maxi Kit (5Prime, Gaithersburg, MD, USA), and concentration and
purity determined with a spectrophotometer (ND-1000, NanoDrop
Technologies, Wilmington, DE, USA). The nt sequences of the inserts of the vector RNAi constructs, termed pXL-BacII_SmU6-shLuc
and pXL-BacII_SmU6-shScramLuc were conﬁrmed, and assigned
GenBank accession numbers HQ677838 and HQ677839,
respectively.
2.4. Preparation of siRNAs, double stranded RNAs (dsRNAs) and ﬁreﬂy
luciferase mRNA
Block-iT™ siRNA of 21 nt in length, speciﬁc for residues 851–871
of ﬁreﬂy luciferase (siLuc), was purchased from Invitrogen (Carlsbad, CA, USA). Long dsRNA speciﬁc for, and spanning the full-length
luciferase coding sequence of 1672 bp was synthesized by in vitro
transcription from a template ampliﬁed by PCR from the ﬁreﬂy
luciferase gene in pGL3 (Promega), using primers (F, 50 -TAA TAC
GAC TCA CTA TAG GG T GCG CCC GCG AAC GAC ATT TA-30 and R,
50 -TAA TAC GAC TCA CTA TAG GGG CAA CCG CTT CCC CGA CTT
CCT TA-30 ) tailed with the T7 promoter sequence). Synthesis and
downstream puriﬁcation of the dsRNA was accomplished using
the Megascript RNAi kit (Ambion, Austin, TX, USA). Integrity of dsRNAs was veriﬁed visually after non-denaturing agarose gel (1%)
electrophoresis. For preparation of ﬁreﬂy luciferase mRNAs (mLuc),
in vitro transcriptions of capped RNAs from template PCR products
were accomplished using the mMessage mMachine T7 Ultra kit
(Ambion) (Correnti and Pearce, 2004; Rinaldi et al., 2008). dsRNA
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or mLuc was precipitated with 1 vol. of 5 M ammonium acetate and
2.5 vol. of 95% ethanol after which the precipitate was dissolved in
water and concentration and purity determined, as above.
2.5. HT1080 cells expressing ﬁreﬂy luciferase
We employed a genetically modiﬁed HT1080 human ﬁbrosarcoma cell line that constitutively expressed luciferase in these studies of vector-based RNAi. Primarily for other studies (Suttiprapa,
Mann and Brindley, unpublished data), we constructed lentiviral
vectors using the ViraPower Gateway system (Invitrogen). In brief,
pLenti6/R4R2/V5-DEST, which includes a gene conferring resistance to blasticidin, was modiﬁed by insertion of the promoter of
the S. mansoni spliced leader RNA gene, upstream of the ﬁreﬂy
luciferase gene (see Kines et al., 2006). The 293FT producer cells
(Invitrogen) were transformed with the construct together with
packaging plasmids delivered in liposomes (Invitrogen). Pseudotyped lentivirus expressing vesicular stomatitis virus (VSV) glycoprotein was harvested from culture media and concentrated by
centrifugation (Sorvall SS-34 rotor) at 48,000g for 90 min at 4 °C.
Pelleted virions were resuspended in Opti-MEM medium (Invitrogen) at 4 °C, after which functional virion titers were determined
using target HT1080 human ﬁbrosarcoma cells (Invitrogen) in the
presence of the antibiotic blasticidin (Invitrogen). To generate a stable HT1080 cell line expressing luciferase, HT1080 cells were transduced with lentivirus virions (titer, 107 transducing units per ml) in
the presence of polybrene (Sigma), and blasticidin-resistant cells,
expressing luciferase, selected by culturing the cells in the presence
of blasticidin for 14 days. Stable cells were isolated and cryopreserved and/or expanded for use as target, luciferase expressing
HT1080 cells for the vector-based RNAi studies described here.
Luciferase expressing HT1080 cells were plated at a density of
5  105 cells/well in 6-well plates (Corning). Fifteen hours later,
the cells were transfected with four or 10 lg of plasmid pXL-BacII_SmU6-shLuc or pXL-BacII_SmU6-shScramLuc or 10 pmol siLuc
using the Lipofectamine 2000 transfection system (Invitrogen). A
control group of cells exposed only to lipofectamine was included.
One day later the cells were washed with PBS, after which plasmid
transformed cells were incubated for 96 h in DMEM supplemented
with 10% FBS, penicillin and streptomycin. Cells were counted and
lysed in CCLR buffer (Promega) in order to determine levels of
luciferase activity (see section 2.7).
2.6. Transfection of schistosomules with plasmids, siRNA and dsRNA
For the studies on RNAi in schistosomes, schistosomules were
transfected with plasmid, dsRNA or siLuc by square wave electroporation. Speciﬁcally, schistosomules were transferred to cuvettes
(4 mm gap, BTX, San Diego, CA, USA) containing media supplemented with 1 lg siLuc, 30 lg dsRNA or 20 lg of plasmid (pXLBacII_SmU6-shLuc or pXL-BacII_SmU6-shScramLuc) and then subjected to a square wave pulse of 125 V of 20 ms duration, using a
BTX ElectroSquarePoratorTM ECM830, as previously described
(Kines et al., 2010). Subsequently, the transfected worms were
transferred to pre-warmed Basch’s medium and maintained in culture for 48 h until mRNA encoding ﬁreﬂy luciferase was introduced
into the cultured worms by electroporation. After electroporation,
the schistosomules were maintained in culture for 3 h and then
washed free of culture media, and wet pellets of worms snap frozen and stored at -80 °C.
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(3  5 s bursts, output cycle 4, Misonix Sonicator 3000, Newtown,
CT 06470, USA) in 300 ll of 1x CCLR lysis buffer (Promega). Pellets
of 1 x 106 HT1080 cells (cell numbers were determined by replicate
counts of Trypan blue-stained cells using a hemacytometer) were
lysed in 300 ll of 1x CCLR lysis buffer. The lysates were clariﬁed
by centrifugation in a microfuge at 4 °C, and analyzed for luciferase
activity. Aliquots of 100 ll of clariﬁed lysate were injected into
100 ll luciferin (Promega) at 25 °C, mixed and the relative light
units (RLUs) determined in a tube luminometer (Sirius, Berthold,
Pforzheim, Germany) 10 s later (Correnti and Pearce 2004; Kines
et al., 2010). Duplicate samples were measured, with results presented as the average of the readings of RLU/s/mg of soluble schistosome protein or, for HT1080 cells, as RLU/s/103 cells. Recombinant
ﬁreﬂy luciferase (Promega) was included as a positive control. The
protein concentration in the soluble fraction of the schistosome extract was determined using the bicinchoninic acid assay (BCA kit,
Pierce, Rockford, IL, USA).
2.8. Statistical analysis
Statistical comparisons were made by ANOVA. When signiﬁcant
differences were found among groups, a Student’s t-test between
controls and treatment conditions was applied, as appropriate.
P-values of 60.05 were considered to be signiﬁcant and P-values
of 60.01 highly signiﬁcant.
3. Results
3.1. Promoter region of the U6 non-coding RNA gene of S. mansoni
An identical match to the S. mansoni U6 gene was located in sequences in contig shisto3397e03.p1k of the draft genome assembly
for S. mansoni. Flanking sequences upstream of the copy of the U6
gene in this contig were targeted for PCR (see section 2.2);
474 bp upstream and ﬂanking the U6 gene as well as part of the
50 -terminus of the U6 gene were ampliﬁed from genomic DNA of
S. mansoni, cloned and sequenced (Fig. 1), therefore conﬁrming
the sequence identity as being identical to that in contig shisto3397e03.p1k. The 270 nt ﬂanking and upstream of this copy of
the S. mansoni U6 gene have been assigned GenBank accession number HQ540317.
The putative S. mansoni U6 promoter and U6 gene were aligned
with those from human (GenBank X07425) and mouse (GenBank
X06980). The schistosome U6 non-coding RNA gene sequence is
96% identical to its human and murine orthologues. The sequence
of the putative promoter upstream of the S. mansoni U6 gene diverged substantially from the mammalian sequences. Notwithstanding, we attempted to locate motifs characteristic of U6 gene
promoters. The enhancer region, also known as the distal sequence
element (DSE), consists of an octamer motif (OCT) and a SphI postoctamer homology (SPH) element. The core region comprises a
proximal sequence element (PSE) and a TATA-like element
(Dahlberg and Schenborn, 1988; Sturm et al., 1988; Schaub et al.,
1999). Based on greater or lesser identity to the human and mouse
motifs, we identiﬁed these prospective motifs of the enhancer and
core regions in the 270 bp ﬂanking the schistosome U6 gene; SPH
element (21 residues), -258 ATTTGGTTGTTTAAAAATATA -238; OCT
(eight residues), -230 ATTACTAT -223; PSE (21 residues), -71
GTGCAAATGAGTGAATGAACG -51; and the TATA box (seven residues), -31 TATGATA -25. These motifs are annotated on the multiple sequence alignment of the U6 genes in Fig. 1.

2.7. Luciferase activity assay
3.2. U6 promoter is active in vector-based RNAi
HT1080 cells and schistosomules were harvested, washed three
times with schistosomule wash medium and stored as wet pellets
at 80 °C. Pellets of schistosomules were subjected to sonication

We constructed plasmids pXL-BacII_SmU6-shLuc and pXL-BacII_SmU6-shScramLuc (Fig. 2A). The short hairpin predicted to be
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Fig. 1. Multiple sequence alignment of the U6 genes of Schistosoma mansoni, Homo sapiens and Mus musculus. The multiple alignment was assembled with ClustalW
(Thompson et al., 1994) using BioEdit, version 7.0.5 (Hall, 1999) and the box shade feature of GeneDoc and the following sequences: S. mansoni (GenBank L25920 (coding
region) and HQ540317 (upstream ﬂanking region)); human, (GenBank X07425), mouse (GenBank X06980). Residue one (black, curved arrow) is the ﬁrst nucleotide (nt) of the
U6 RNA gene sequence. Characteristic motifs of the enhancer and core regions of the U6 gene promoter are identiﬁed or predicted (red colored rectangles). The enhancer
distal sequence element includes an octamer motif (OCT) and SphI post-octamer homology (SPH) element and the core region comprises a proximal sequence element (PSE)
and a TATA-like element. Consensus sequences are indicated under the PSE and OCT motifs. Note that the relative positions for the SPH and OCT elements are reversed in
mouse U6.
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Fig. 2. Episomal vector-based RNA interference (RNAi) of ﬁreﬂy luciferase activity in human ﬁbrosarcoma HT1080 cells. A) Schematic illustration of the insert of plasmid of
pXL-BacII_SmU6-shLuc, including the inverted terminal repeats (ITR) ﬂanking the short hairpin (sh)RNA cassette, the Schistosoma mansoni U6 gene promoter, the sense strand
(21 nucleotide (nt), residues 851–871 of the gene encoding ﬁreﬂy luciferase, the nine residue loop, the 21 nt anti-sense strand and the TTTTTT terminator residues. The
predicted shRNA is shown below the plasmid construct. B) Luciferase activity in HT1080 cells expressed as relative light units (RLU)/s/103 cells. HT1080 cells were transfected
with 1 lg of small interfering RNA of 21 nt in length, speciﬁc for residues 851–871 of ﬁreﬂy luciferase (siLuc) ; 4 lg pXL-BacII_SmU6-shLuc (shLuc_4 lg); 10 lg of pXLBacII_SmU6-shLuc (shLuc_4 lg); 4 lg plasmid pXL-BacII_SmU6-shScramLuc (shScrambled_4 lg); 10 lg of control plasmid pXL-BacII_SmU6-shScramLuc (shScrambled_10 lg); and no treatment control (mock). Bars are ± S.D. (n = 2). Signiﬁcant differences between treated groups and the (mock) control are indicated: ⁄, P 6 0.05;
⁄⁄, P 6 0.01.
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transcribed from the U6 promoter of this episome includes the 21
nt sense strand speciﬁc for residues 851–871 of the luciferase
transcript, a loop of nine residues, the 21 residue antisense strand,
and the UUUUU termination signal. The control construct pXL-BacII_SmU6-shScramLuc includes the same residues in the target
strand, but the order of the residues was scrambled. First, we transfected HT1080 cells with the vector based RNAi constructs. A
HT1080 cell line that stably expressed ﬁreﬂy luciferase was used
for this experiment, with the aim of vector-based RNAi targeting
the ‘endogenous’ luciferase. At 96 h after transfection with the
vector RNAi plasmids or with siRNA, statistically signiﬁcant knockdown of luciferase activity was evident. In particular, luciferase
activity was reduced by 54.3% and 47.5% in HT1080 cells transfected with 4 or 10 lg of pXL-BacII_SmU6-shLuc, respectively, compared with untreated, control HT1080 cells (both P 6 0.01), and
by 30.2% in cells exposed to the siRNA transfected cells (P 6
0.05). By contrast, no reduction in luciferase activity was evident
in cells transfected with the control construct, pXL-BacII_SmU6shScramLuc (Fig. 2B). Similar ﬁndings were observed in each of
two biological replicates of this experiment. These results indicated that the putative S. mansoni U6 promoter drives short hairpin
expression in a human cell line against an endogenously expressed
reporter gene.
3.3. Schistosome U6 promoter-driven shRNA induces RNAi in
schistosomules
The activity of pXL-BacII_SmU6-shLuc was examined in cultured schistosomules. At 48 h after transfection with the vector
RNAi plasmid, or with dsRNA or siRNA, statistically signiﬁcant
knockdown of luciferase activity was evident. Speciﬁcally, luciferase activity was reduced by 47.5% in schistosomules transfected
with 20 lg of pXL-BacII_SmU6-shLuc compared with schistosomules treated with 20 lg of the control plasmid, pXL-BacII_SmU6shScramLuc (183,030.5 versus 348,651.3 RLU/s/mg) (P 6 0.05)
(Fig. 3). The RNAi induced with dsRNA or siRNA was even greater
than that with pXL-BacII_SmU6-shLuc, both > 95% knockdown of
luciferase activity compared with the worms transfected with the
control plasmid, pXL-BacII_SmU6-shScramLuc (P 6 0.01). More
luciferase activity was seen in schistosomules not transfected with
any nucleic acids (P 6 0.01), a control group that was termed
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‘mock’ (Fig. 3). Similar ﬁndings were observed in three of four replicates of the experiment.
4. Discussion
RNAi is a widely employed approach in reverse genetics for speciﬁc knockdown of target genes. The RNAi mechanism is conserved
among eukaryotes, including schistosomes (see Krautz-Peterson
et al., 2010). RNAi is triggered by dsRNA and results in inactivation
of the target gene through degradation of homologous mRNAs and/
or inhibition of mRNA translation. In the context of vector-based
RNAi, the molecular biology of RNAi has been reviewed (e.g., Cheng
and Chang, 2007; Sliva and Schnierle, 2010). In brief, episomal or
integrated transgenes, comprising pol III promoters driving target
sequence-speciﬁc cassettes, lead to over-expression of shRNAs, of
21 nt of stem (range 19–29 nt) and 9 nt (range 4–23) of loop sequences (Brummelkamp et al., 2002; Miyagishi and Taira, 2002;
Paddison et al., 2002). After export from the nucleus the shRNA
is cleaved by Dicer and enters the RNA-induced silencing complex,
which unwinds the RNA and targets the speciﬁc mRNA for degradation. Vector-based RNAi provides advantages over the direct
introduction of siRNA or dsRNA to target cells, including long-term
and/or conditional gene silencing. It also can be cost effective, given that synthesis of siRNA is expensive, its effect transient and
in addition, long dsRNA can induce a cytotoxic response in mammalian cells (Williams, 1999). On the other hand, the RNAi effect
using a vector-based system is more stable due to sustained production of shRNA.
We isolated 270 bp of genomic DNA ﬂanking the S. mansoni U6
small nRNA gene, a component of the spliceosome machinery (see
Copeland et al., 2009), and constructed a RNAi expression cassette
using this putative promoter to drive expression of shRNAs speciﬁc
for ﬁreﬂy luciferase. We observed signiﬁcant knockdown of luciferase in human ﬁbrosarcoma cells and in schistosomules transfected
with the expression cassette. The ﬁndings demonstrated that the S.
mansoni U6 gene promoter drove shRNA expression that induced
RNAi in a human cell and in schistosomules. In addition to schistosome and human U6 gene promoters, orthologous U6 promoters
from pathogenic amebae, Drosophila, sea squirts, fugu ﬁsh, chicken
and bovines also function in Pol III driven vector-based RNAi
expression systems (Lambeth et al., 2005; Wakiyama et al., 2005;

Fig. 3. Episomal vector-based RNA interference (RNAi) of ﬁreﬂy luciferase activity in 1 day old schistosomules. Luciferase activity in schistosomules expressed as relative
light units (RLU)/s/mg of protein. One day old schistosomules were electroporated in the absence of plasmid or RNAs (mock), 30 lg of ﬁreﬂy luciferase double stranded RNA
(dsLuc), 10 lg of small interfering RNA of 21 nt in length, speciﬁc for residues 851–871 of ﬁreﬂy luciferase (siLuc), 20 lg of control plasmid pXL-BacII_SmU6-shScramLuc
(ShScram) and 20 lg of plasmid pXL-BacII_SmU6-shLuc (shLuc). Bars are ± S.D. (n = 2). Signiﬁcant differences between treated groups and the (mock) control are indicated:
⁄, P 6 0.05; ⁄⁄, P 6 0.01.
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Wise et al., 2007; Nishiyama and Fujiwara, 2008; Zenke and Kim,
2008; Linford et al., 2009).
Although this S. mansoni U6 gene promoter is active in schistosomes and in HT1080 cells, the knockdown experiments performed in HT1080 cells were more consistent and reproducible
than those with schistosomules. However, even in HT1080 cells
we did not observe a concentration effect; 10 lg did not induce
signiﬁcantly greater silencing than 4 lg of pXL-BacII_SmU6 shLuc.
This may reﬂect saturation of the cellular microRNA/shRNA pathway leading to competition for limited cellular factors such as nuclear karyopherin exportin-5 (see Grimm et al., 2006; Snøve and
Rossi, 2006). The non-speciﬁc reduction of luciferase activity in
schistosomules detected in the control shRNA group may reﬂect
dysfunction of the mRNA translation machinery. Schistosomules
clearly are less tractable for these approaches than mammalian cell
lines but since functional genomics tools are needed for schistosomes, and because cell lines are not available for schistosomes,
we have targeted larval schistosomes here to investigate a prospective new approach (Mann et al., 2008, 2010). Cultured
HT1080 cells not only have a larger surface area, but here were
transfected only once with the vector short hairpin plasmid
whereas the schistosomules were transfected with this plasmid
and, secondly, with the mRNA encoding luciferase. Exposing
worms twice to electroporation may be deleterious and reﬂected
in inconsistent outcomes in the replicates. Moreover, knockdown
of luciferase in these particular HT1080 cells represented silencing
of an ‘endogenous’ gene since the cells expressed ﬁreﬂy luciferase
from integrated lentiviral transgenes. Perhaps most critical was
that since schistosomules are multicellular, some but not all of
the cells were transformed with both pXL-BacII_SmU6-shLuc and
luciferase mRNA. Cells of the digestive tract and/or tegument are
likely transduced by the plasmid and/or the mRNA, whereas more
internal cells may not have been transfected. Nonetheless, we can
predict that after entry into the schistosome cell, the episome was
transcribed and processed, and the siRNAs transmitted to adjacent
cells by transporters such as Sid 1 (Krautz-Peterson and Skelly,
2008). In this regard and to improve assay reproducibility, increasing the time between the plasmid and the luciferase mRNA transfection might be beneﬁcial so that siRNAs might spread from the
transfected cells, leading to enhanced knockdown.
Recently, proof-of-principle for vector-based RNAi was demonstrated in S. mansoni, using a MLV (retrovirus) vector (Tchoubrieva
et al., 2010). However, those investigators used a RNA polymerase
II dependent promoter and a long hairpin of 120 bp targeting a
protease involved in hemoglobinolysis. Whereas this retroviral
vector-based RNAi system is functional, there may be advantages
to deploying a Pol III dependent promoter: the U6 promoter is
known to competently and continuously transcribe small RNAs,
is highly active in all or most cells and tissues, and its diminutive
size ﬁts within the limits on cargo size of the expression cassette
(Paddison et al., 2002; Scherr and Eder, 2007). The signiﬁcance of
both ﬁndings with vector-based RNAi in schistosomes, the present
ﬁndings and those of Tchoubrieva et al. (2010) is that vector-based
RNAi should allow targeting of any schistosome gene for continuous knockdown and subsequent examination of the importance of
the targeted gene. Moreover, plasmid pXL-BacII, from which we
constructed pXL-BacII_SmU6-shLuc, contains the inverted terminal
repeats of transposon piggyBac (Li et al., 2005). Given that piggyBac is transpositionally active in S. mansoni (Morales et al., 2007),
pXL-BacII_SmU6-shLuc could be utilized to generate transgenic
schistosomes, that inherit trans-generational silencing of report
luciferase, by co-transfecting schistosomes with this shRNA inducing plasmid along with the piggyBac transposase.
High throughput RNAi analysis will advance functional
genomics for schistosomes, and indeed parasitic helminths at
large. We anticipate that the information presented here describ-

ing the schistosome U6 promoter and its activity in vector-based
RNAi will contribute to establishment of these analyses. We are
interested to establish long-term, stable and trans-generational
RNAi to aid discovery of essential schistosome genes which could,
in turn, be targeted in new approaches for treatment and control
of schistosomiasis.
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